BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25136365)

  • 1. Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review.
    Boukhris M; Tomasello SD; MarzĂ  F; Bregante S; Pluchinotta FR; Galassi AR
    Int J Endocrinol; 2014; 2014():413920. PubMed ID: 25136365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estrogens for prevention of coronary heart disease?].
    Meinertz T
    Herz; 1997 Jun; 22(3):151-7. PubMed ID: 9303898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of hormone replacement therapy on plasma lipids in type II diabetes.
    Manwaring P; Morfis L; Diamond T; Howes LG
    Maturitas; 2000 Mar; 34(3):239-47. PubMed ID: 10717490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive hormones and cardiovascular disease mechanism of action and clinical implications.
    Wagner JD; Kaplan JR; Burkman RT
    Obstet Gynecol Clin North Am; 2002 Sep; 29(3):475-93. PubMed ID: 12353669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in women and noncontraceptive use of hormones: a feminist analysis.
    MacPherson KI
    ANS Adv Nurs Sci; 1992 Jun; 14(4):34-49. PubMed ID: 1605587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus.
    Xu Y; Lin J; Wang S; Xiong J; Zhu Q
    Kaohsiung J Med Sci; 2014 Jul; 30(7):350-61. PubMed ID: 24924841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
    Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
    JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I; Parra D
    Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and cardiovascular disease: lessons from a monkey model of postmenopausal women.
    Williams JK; Suparto I
    ILAR J; 2004; 45(2):139-46. PubMed ID: 15111733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women.
    Abu-Halawa SA; Thompson K; Kirkeeide RL; Vaughn WK; Rosales O; Fujisi K; Schroth G; Smalling R; Anderson HV
    Am J Cardiol; 1998 Aug; 82(4):409-13. PubMed ID: 9723624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone replacement therapy on cardiovascular responses in postmenopausal women with and without type 2 diabetes.
    Manwaring P; Phoon S; Diamond T; Howes LG
    Maturitas; 2002 Nov; 43(3):157-64. PubMed ID: 12443833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis prevention and treatment with sex hormone replacement therapy.
    Rozenberg S; Kroll M; Pastijn A; Vandromme J
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():14-7. PubMed ID: 8846655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between estrogen replacement therapy and heart failure in postmenopausal women: A systematic review and meta-analysis.
    Chen Z; Wu C; Huang Z
    Prev Med; 2024 Apr; 181():107909. PubMed ID: 38382766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R; Theriault RL
    J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement in postmenopausal women: impact of progestogens on autonomic tone and blood pressure regulation.
    Christ M; Seyffart K; Tillmann HC; Wehling M
    Menopause; 2002; 9(2):127-36. PubMed ID: 11875332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.